SPOTLIGHT -
Slideshow
Author(s):
Some speculate the pharmaceutical industry has virtually abandoned new drug development in neuroscience with a few exceptions. However, it should be noted that progress has been made.
April in Review: Updates on the Psychiatric Treatment Pipeline
Blue Light Blockers: A Behavior Therapy for Mania
Transneural Therapeutics: A New Company to Develop Novel Neuroplastogens
Blue Light, Depression, and Bipolar Disorder
MindMed Begins Phase 3 Emerge Study of MM120 in Patients With Major Depressive Disorder
Investigating the SAINT iTBS Protocol for Bipolar I Depression